Data for Understanding Perception of Implementers on Prime Vendor System in Tanzania Mainland.doc
收藏DataCite Commons2024-07-30 更新2024-08-19 收录
下载链接:
https://figshare.com/articles/dataset/Data_for_Understanding_Perception_of_Implementers_on_Prime_Vendor_System_in_Tanzania_Mainland_doc/26380141
下载链接
链接失效反馈官方服务:
资源简介:
Access to safe, effective, quality and affordable essential medicines for all is a central component of Universal Health Coverage (UHC). However, the availability of quality medicines in low and middle-income countries is often limited, especially in peripheral health facilities. MSD, as the sole supplier of drugs and medical supplies to all public health facilities, has been facing difficulties that hinder its efficiency in supplying 100% of all facility’s needs (HRSC-2017). Despite significant reforms, including introducing the Prime Vendor System in 2018, challenges persist, leading to regional disparities in commodity availability at the facility level. Successfully establishing an intervention based on PPPs within the public sector in the health commodities supply chain system mostly requires high acceptability by the Government, implementers, and the beneficiaries of the intervention (Kumurya, 2015), (Kuwawenaruwa et al., 2020) and (Wiedenmayer et al., 2019). Furthermore, the effectiveness of any activity is primarily influenced by the participants' attitudes. While most studies have extensively researched the effectiveness of the prime vendor system in bridging the supply chain gap, none have researched implementers' perceptions of the prime vendor system in complementing health commodities. This study seeks to understand the Implementer's perceptions of the prime vendor system implementation
人人享有安全、有效、优质且可负担的基本药物,是全民健康覆盖(Universal Health Coverage, UHC)的核心组成部分。然而,中低收入国家的优质药物可及性往往受限,尤其是在基层医疗卫生机构。默沙东(MSD)作为所有公立医疗卫生机构的药品与医疗用品唯一供应商,此前面临诸多阻碍其高效足额满足所有机构物资供应需求的难题(HRSC-2017)。尽管2018年引入核心供应商制度(Prime Vendor System)等多项重大改革,相关挑战仍未消除,导致机构层面的医疗物资可及性存在区域差异。在公共部门的医疗用品供应链体系中成功推行基于公私合作伙伴关系(Public-Private Partnerships, PPPs)的干预措施,通常需要获得政府、实施方与干预受益方的高度认可(Kumurya, 2015; Kuwawenaruwa et al., 2020; Wiedenmayer et al., 2019)。此外,任何活动的有效性主要受参与者态度的影响。既往多数研究已就核心供应商制度在弥补供应链缺口方面的有效性展开了广泛探讨,但尚无研究聚焦于实施方对该制度在补充医疗物资供应方面的认知情况。本研究旨在了解实施方对核心供应商制度实施的认知状况。
提供机构:
figshare
创建时间:
2024-07-26



